HENRY SCHEIN INC

For the period ended Dec 30, 2023. Filed Feb 28, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 28, 2024

HSIC$88.41+2.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange

Act of 1934, the Registrant has duly

caused this report to be signed on its behalf by the undersigned,

thereunto duly authorized.

By: /s/ STANLEY M. BERGMAN

Chairman and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this

report has been signed below by the

following persons on behalf of the Registrant and in the capacities and on

the dates indicated.

Signature

Capacity

Date

/s/ STANLEY M. BERGMAN

Chairman, Chief Executive Officer

and Director (principal executive officer)

/s/ RONALD N. SOUTH

Senior Vice President, Chief

Financial Officer

(principal financial and accounting officer)

/s/ JAMES P.

BRESLAWSKI

Vice Chairman, President

and Director

James P.

Breslawski

/s/ MARK E. MLOTEK

Executive Vice President,

Chief Strategic Officer and

/s/ MOHAMAD ALI

Mohamad Ali

/s/ DEBORAH DERBY

Deborah Derby

/s/ CAROLE T. FAIG

Carole T. Faig

/s/ JOSEPH L. HERRING

Joseph L. Herring

/s/ KURT P.

KUEHN

Kurt P.

Kuehn

/s/ PHILIP A. LASKAWY

Philip A. Laskawy

/s/ ANNE H. MARGULIES

Anne H. Margulies

/s/ STEVEN PALADINO

Steven Paladino

/s/ CAROL RAPHAEL

Carol Raphael

/s/ SCOTT SEROTA

Scott Serota

/s/ BRADLEY T. SHEARES,

PH.D.

Bradley T. Sheares,

Ph.D.

/s/ REED V.

TUCKSON, M.D., FACP

Reed V.

Tuckson, M.D., FACP

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.